Woodline Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-46,260
Closed -$7.58M 1135
2025
Q4
$7.58M Sell
46,260
-59,189
-56% -$9.27M 0.03% 530
2025
Q3
$14.1M Buy
105,449
+95,181
+927% +$11.6M 0.07% 352
2025
Q2
$1.28M Sell
10,268
-45,938
-82% -$5.85M 0.01% 782
2025
Q1
$7.15M Buy
+56,206
New +$8.65M 0.05% 423

Other funds holding RGEN

Woodline Partners's RGEN Position: Q1 2026 in Review

Woodline Partners sold out of Repligen (RGEN) in Q1 2026, closing a stake of 46,260 shares — an estimated $7.58M sold.

Woodline Partners first reported a position in RGEN in Q1 2025 and held it in 4 quarters. The position peaked at $14.1M in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Woodline Partners reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Woodline Partners sold 46,260 Repligen shares in Q1 2026, an estimated $7.58M.
  • Woodline Partners first reported a position in Repligen in Q1 2025 and held it in 4 quarters.
  • Woodline Partners's Repligen position peaked at $14.1M in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.